OCULAR THERAPEUTIX INC (OCUL) Stock Analyst Ratings
USA - NASDAQ:OCUL - US67576A1007 - Common Stock
11.82 USD
+0.34 (+2.96%)
11.82 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to OCUL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.19. This target is 53.89% above the current price.
OCUL was analyzed by 18 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about OCUL.
In the previous month the buy percentage consensus was at a similar level.
OCUL was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-03 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-02 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-01 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-10-01 | Needham | Maintains | Buy -> Buy |
| 2025-09-15 | Chardan Capital | Initiate | Buy |
| 2025-08-06 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-08-05 | Needham | Maintains | Buy -> Buy |
| 2025-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-06 | Needham | Maintains | Buy -> Buy |
| 2025-04-08 | William Blair | Initiate | Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-18 | RBC Capital | Initiate | Outperform |
| 2025-03-11 | Needham | Initiate | Buy |
| 2025-03-04 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-20 | TD Cowen | Upgrade | Hold -> Buy |
| 2024-06-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | TD Cowen | Maintains | Hold -> Hold |
| 2024-05-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
OCULAR THERAPEUTIX INC / OCUL FAQ
What is the average price target for OCULAR THERAPEUTIX INC (OCUL) stock?
18 analysts have analysed OCUL and the average price target is 18.19 USD. This implies a price increase of 53.89% is expected in the next year compared to the current price of 11.82.
What is the consensus rating for OCUL stock?
The consensus rating for OCULAR THERAPEUTIX INC (OCUL) is 85.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.